Levothyroxine Review Standards Should Be Same For ANDAs, Brands – Petition
Executive Summary
Levothyroxine generics should be held to the same review standards as their 505(b)(2) counterparts, Unithroid manufacturer Jerome Stevens maintained in a 1citizen petition to FDA
You may also be interested in...
Tighter Levothyroxine Standards Are Only First Step To Higher Quality – Cmte.
Tightening levothyroxine potency standards will not address underlying concerns about the quality of the manufacturing process for such products, members of the Endocrinologic & Metabolic Drugs and Pharmaceutical Science Advisory Committees said
Tighter Levothyroxine Standards Are Only First Step To Higher Quality – Cmte.
Tightening levothyroxine potency standards will not address underlying concerns about the quality of the manufacturing process for such products, members of the Endocrinologic & Metabolic Drugs and Pharmaceutical Science Advisory Committees said
Levothyroxine Bioequivalence Studies Need Thyroid-Free Baseline – Abbott
FDA should require generic companies to conduct levothyroxine bioequivalence studies in athyreotic patients as a condition of ANDA approval, Abbott suggests in an Aug. 25 citizen petition